Cardiac Impairments Following Pediatric Cardiotoxic Anti-cancer Treatment

November 30, 2023 updated by: Sabine Kesting, Technical University of Munich

Early Detection of Cardiac Impairments Following Cardiotoxic Anti-cancer Treatment During Childhood and Adolescence - A Feasibility Study

This study aims at investigating the feasibility of recruitment and application of a method regarding early detection of subclinical changes in cardiac health after completion of acute cancer treatment during childhood and adolescence.

Study Overview

Status

Enrolling by invitation

Detailed Description

Cardiovascular late effects following treatment for pediatric cancer are problematic. Early detection of subclinical changes is hardly possible using conventional diagnostic methods, but seems to be feasible during physical strain (exercise stress echocardiography).

This feasibility study examines as main objective the recruitment strategy and investigation method in 10-25-year olds in the first and fifth year after the end of acute anti-cancer therapy (n=40 participants with a history of childhood cancer and n=40 control subjects). The heart function is examined by means of exercise stress echocardiography and spiroergometry in comparison with healthy age- and gender-matched control subjects.

Secondary aims are the evaluation of aditional echocardiography markers and levels of physical activity.

Study Type

Observational

Enrollment (Estimated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Munich, Germany, 80992
        • Institute of Preventive Pediatrics, Department of Sport and Health Sciences, Technical University of Munich, Germany

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 25 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Participants with a history of pediatric cancer will be recruited during appointments in follow-up care at two departments for pediatric cancer in Munich.

Healthy peers will be recruited within social environment of participants with a history of cancer (siblings, close friends) and within schools and sport clubs.

Description

Inclusion criteria for all participants:

  • Aged between 10 and 25 years
  • Body height of ≥1,40m (required for performing the examination on the semi supine bicycle ergometer)
  • Signed informed assent (minor participant) and consent (legal guardian and full-aged participant)

Additional inclusion criteria for participants following cancer treatment:

  • Completion of acute cancer treatment with anthracyclines and/or chest radiation
  • End of treatment 12 months and five years ago (± three months)
  • Medical approval for study participation

Additional inclusion criteria for healthy control subjects:

- Appropriate as matched pair with respect to age and gender

Exclusion Criteria:

  • Known cardiovascular diseases (incoherent with cardiotoxic treatment)
  • Inability to follow study instructions (e.g., mental retardation, language)
  • Acute orthopedic injury (e.g., bone fracture) or orthopedic impairments that preclude examination on a bicycle ergometer (e.g., instable prosthetic device)

All participants receive a basic physical and cardiological examination at rest as part of the study protocol to ensure capability before performing the exercise stress echocardiography.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Participants treated for pediatric cancer
This group includes children, adolescents and young adults treated for pediatric cancer who received anthracyclines and/or chest radiation during treatment.
Study participants perform an exercise stress echocardiography on a semi-supine bicycle ergometer using using a continuous incremental bicycle protocol with a work rate increment every 3 minutes according to gender and weight.
Healthy control subjects
This group includes healthy children, adolescents and young adults without a history of pediatric cancer as age-and gender-matched control subjects.
Study participants perform an exercise stress echocardiography on a semi-supine bicycle ergometer using using a continuous incremental bicycle protocol with a work rate increment every 3 minutes according to gender and weight.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility Criteria 1 - Recruitment Rate
Time Frame: Throughout study completion, an average of 2 years
The number of children, adolescents and young adults with a history of pediatric cancer who agree to participate compared to the total number approached for this study.
Throughout study completion, an average of 2 years
Feasibility Criteria 2 - Acceptance
Time Frame: Throughout study completion, an average of 2 years
Number of finished and discontinued exercise stress echocardiographies.
Throughout study completion, an average of 2 years
Feasibility Criteria 3 - Data Quality
Time Frame: Throughout study completion, an average of 2 years
Number of evaluable examination data.
Throughout study completion, an average of 2 years
Feasibility Criteria 4 - Practicability
Time Frame: Throughout study completion, an average of 2 years
Difference between scheduled and required time frame for the single examination.
Throughout study completion, an average of 2 years
Feasibility Criteria 5 - Participants' Feedback
Time Frame: Throughout study completion, an average of 2 years
Feedback questionnaire with multiple choice options and free text answers.
Throughout study completion, an average of 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reference Values of Healthy Peers
Time Frame: Throughout study completion, an average of 2 years
Assessment of reference values from age- and gender-matched healthy peers (matched pairs).
Throughout study completion, an average of 2 years
Analysis of Echocardiography Marker 1
Time Frame: During the procedure
Deformation Parameters in % (global longitudinal strain and circumferencial strain)
During the procedure
Analysis of Echocardiography Marker 2
Time Frame: During the procedure
Ejection Fraction (EF) in %
During the procedure
Analysis of Echocardiography Marker 3
Time Frame: During the procedure
M-Mode Parameter
During the procedure
Analysis of Echocardiography Marker 4
Time Frame: During the procedure
Tricuspid Annular Plane Systolic Excursion (TAPSE) in millimeter
During the procedure
Analysis of Echocardiography Marker 5
Time Frame: During the procedure
Left ventricle end diastolic volume (LVEDV) in ml/m²
During the procedure
Cardiorespiratory Fitness
Time Frame: During the procedure
Submaximal oxygen uptake VO2peak (ml/kg/min)
During the procedure
Physical Activity Level post-therapy
Time Frame: During the procedure
For participants with a history of pediatric cancer: Physical activity questionnaire ActiOn post-therapy for the assessment of the amount of moderate-to-vigorous physical activity.
During the procedure
Physical Activity Level in Healthy Control Subjects
Time Frame: During the procedure
For healthy control subjects: Physical activity questionnaire from the KiGGS study (German Health Interview and Examination Survey for Children and Adolescents).
During the procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Renate Oberhoffer-Fritz, Prof. Dr. med., Institute of Preventive Pediatrics, Department of Sport and Health Sciences, TUM

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Estimated)

October 31, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

December 14, 2021

First Submitted That Met QC Criteria

February 17, 2022

First Posted (Actual)

March 2, 2022

Study Record Updates

Last Update Posted (Actual)

December 5, 2023

Last Update Submitted That Met QC Criteria

November 30, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • German Heart Foundation

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on Exercise stress echocardiography

Subscribe